NCT00024232View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

monoclonal antibody huJ591

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00024232 - Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter